Figure 4
Figure 4. Effect of FcγR signaling pathways on KKO-induced platelet and fibrin accretion. FcγRIIA, FcγRI, FcγRIII, and FcγRIIA plus FcγRI signaling was blocked in whole blood samples as in studies shown in Figure 2 for (A) platelet accretion, and (B) fibrin generation. Relative platelet accretion and fibrin generation are expressed as the ratio of results from samples blocked with specific mAb to samples pre-incubated with isotype control. Mean ± 1 SEM is shown. Dotted line represents the relative value for the isotype control; values below the dotted line means inhibition after blockade of the indicated FcγR compared with isotype control with P values shown relative to that control. Significance was determined using two-tailed Student t tests when comparing FcγR to the isotype control, each stimulated with PF4 and KKO. N = 10 with samples from 5 donors. (C-D) are as (A-B) respectively, but with isolated monocytes that were then used to reconstitute whole blood as in Figure 3. n.s., not statistically significant between blocking FcγRIIA and blocking FcγRIIA plus FcγRI.

Effect of FcγR signaling pathways on KKO-induced platelet and fibrin accretion. FcγRIIA, FcγRI, FcγRIII, and FcγRIIA plus FcγRI signaling was blocked in whole blood samples as in studies shown in Figure 2 for (A) platelet accretion, and (B) fibrin generation. Relative platelet accretion and fibrin generation are expressed as the ratio of results from samples blocked with specific mAb to samples pre-incubated with isotype control. Mean ± 1 SEM is shown. Dotted line represents the relative value for the isotype control; values below the dotted line means inhibition after blockade of the indicated FcγR compared with isotype control with P values shown relative to that control. Significance was determined using two-tailed Student t tests when comparing FcγR to the isotype control, each stimulated with PF4 and KKO. N = 10 with samples from 5 donors. (C-D) are as (A-B) respectively, but with isolated monocytes that were then used to reconstitute whole blood as in Figure 3. n.s., not statistically significant between blocking FcγRIIA and blocking FcγRIIA plus FcγRI.

Close Modal

or Create an Account

Close Modal
Close Modal